Skip to main content
309-OR: Improvement in Day and Night Glycemic Outcomes with an AI-Based Fully Closed Loop (FCL) System Compared with Hybrid Closed Loop (HCL) in Adults, Young Adults, and Adolescents with Type 1 Diabetes (T1D).
2106-LB: The Use of Continuous Glucose Monitoring to Diagnose Stage 2 Type 1 Diabetes.
2105-LB: Limited Readiness for Type 1 Diabetes (T1D) Autoantibody Screening and Metabolic Monitoring among Pediatric and Adult Diabetes Centers in the T1DX-Quality Improvement Collaborative (T1DX-QI).
1185-P: Determining Accuracy of Continuous Glucose Monitoring in Pediatric Patients in the Inpatient Setting.
1183-P: Neighborhood Level Deprivation Is a Key Predictor of Glycemic Outcomes in Youth-Onset Type 2 Diabetes.
1910-LB: Disparities in Initiation of Continuous Glucose Monitoring and Impact on Glycemic Control in Children and Adolescents with Type 1 Diabetes.
147-OR: Obesity Is Associated with Increased Clearance and Reduced Drug Exposure to Metformin in Youth with Type 2 Diabetes.
1304-P: MODY Calculator Overestimates MODY Probability in Multiethnic Cohort with Youth-Onset Type 2 Diabetes Phenotype.
146-OR: Clustering Pediatric Type 2 Diabetes Patients Exposes Differential Responses to Therapeutic Interventions.
Increased genetic risk for β-cell failure is associated with β-cell function decline in people with prediabetes.